Identification of resistance mechanisms to EGFR treatment in the real world using a clinicogenomic database Published April 2018 Citation Singal, G, Li, G, Agarwala, V, Kaushik, G, O’Connell, C, Alpha-CobbG, Caron, T, Bourque, D, Guria, A, Frank, S, Frampton, G, Carson, K, Abernethy, A.P., Miller, V.A. . AACR Annual Meeting. . https://4076230.fs1.hubspotusercontent-na1.net/hubfs/4076230/flatiron-com-pdf/AACR-2018-FH-FMI-CGDB-Poster-180411.pdf Authors: Sources:American Association for Cancer Research Annual Meeting Share Posted inPublicationsDrug discovery More publicationsJSMO Annual MeetingMarch 2026Japanese language EHR LLM extraction of longitudinal unstructured ECOG performance statusAdamson B, Zhang Y, Chamby A, et al.Publication summaryPublicationsMachine learningArtificial intelligenceJSMO Annual MeetingMarch 2026Real-world clinical characteristics and treatment patterns in patients with colorectal cancer (CRC) in JapanBando H, Ng D, Nasu I, Tajima E, Adamson B.Publication summaryPublicationsColorectal cancerTher Innov Regul SciMarch 2026RWE Submission for European Regulators and Payers: Challenges, Uncertainties, and OpportunitiesTaylor L, Adamson B.Publication summaryPublicationsRegulatoryHTA and market access